Dotmatics ups workflow service for biologics research

By Flora Southey contact

- Last updated on GMT

GettyImages/isak55
GettyImages/isak55
Dotmatics has expanded its workflow capabilities to capture experiments and processes, and track projects for biologics discovery.

The UK-headquartered firm – which offers informatics services – said its biologics suite is designed to enable data sharing, and facilitate cross-company collaborations.

The company’s Bioregister software captures a variety of data types, including antibodies, conjugates, chemically modified nucleotides and peptides, as well as cell lines and vectors, said the firm.  

The spokesperson told us the platform also benefits biomanufacturers in the downstream space.

“Having effective, high-fidelity IT systems…in place from the very start of projects, that track all aspects (entities, processes, etc.) of the project, allows this critical information to be passed to downstream biomanufacturing systems,” ​we were told.

According to Dotmatics, many biologics discovery-focused organisations are still using manual ad-hoc processes, including paper laboratory notebooks, to capture and share data.

“These often involve large numbers of spreadsheets and other documents sent by email or sharepoint,” ​a spokesperson told us.

Collating data into files is time-consuming and can lead to transcription errors, the spokesperson added.

Other challenges when using manual systems include data collaborations, intellection property (IP) and breadth of scientific data types, said the firm.

“Many research projects are now collaborations across organisations and so tracking IPownership and ensuring data security and integrity become extremely problematic with file shares and email-based systems,” ​said Dotmatics.

Related news

Related products

show more

VDS groß

Meet the challenges of complex injectables

Vetter Pharma International GmbH | 07-Nov-2017 | Technical / White Paper

In the time it takes from the exciting discovery phase to the rigorous demands of a commercial launch, unexpected scientific and technical challenges can...

lyo_vials

Process Development for Lyophilized Products

Baxter BioPharma Solutions | 30-Oct-2017 | Application Note

Baxter approaches formulation and process development with the intention of identifying the failure points for the product. Knowing where the product fails...

Ocopeptides

Advancing therapeutics for myeloma

Recipharm AB | 04-Sep-2017 | Case Study

Multiple myeloma is the second most common blood cancer in the world and despite survival rates increasing over the last decade, there remains a requirement...

Related suppliers